ES2055201T3 - Sistema terapeutico transdermal con flujo aumentado de sustancia activa y tratamiento para su fabricacion. - Google Patents

Sistema terapeutico transdermal con flujo aumentado de sustancia activa y tratamiento para su fabricacion.

Info

Publication number
ES2055201T3
ES2055201T3 ES90105527T ES90105527T ES2055201T3 ES 2055201 T3 ES2055201 T3 ES 2055201T3 ES 90105527 T ES90105527 T ES 90105527T ES 90105527 T ES90105527 T ES 90105527T ES 2055201 T3 ES2055201 T3 ES 2055201T3
Authority
ES
Spain
Prior art keywords
therapeutic system
transdermal therapeutic
manufacture
treatment
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90105527T
Other languages
English (en)
Inventor
Michael Dr Horstmann
Fritz Dr Herrmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2055201T3 publication Critical patent/ES2055201T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Abstract

UN SISTEMA TERAPEUTICO TRANSDERMAL CON MONTAJE DE CAPAS SE COMPONE DE UNA CAPA POSTERIOR IMPERMEABLE A LA SUSTANCIA ACTIVA, UNA MATRIZ CON UN MATERIAL BASE INDISOLUBLE EN EL AGUA E ISLAS DISTRIBUIDAS QUE CONTIENEN LA SUSTANCIA ACTIVA MEDICA Y UNA CAPA QUE CONTROLA EL ACCESO DE LA HUMEDAD DE PIEL, POR LA QUE SE ACTIVA LA MATRIZ. SE DESCRIBEN PROCEDIMIENTOS DE FABRICACION.
ES90105527T 1989-04-01 1990-03-23 Sistema terapeutico transdermal con flujo aumentado de sustancia activa y tratamiento para su fabricacion. Expired - Lifetime ES2055201T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3910543A DE3910543A1 (de) 1989-04-01 1989-04-01 Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
ES2055201T3 true ES2055201T3 (es) 1994-08-16

Family

ID=6377599

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90105527T Expired - Lifetime ES2055201T3 (es) 1989-04-01 1990-03-23 Sistema terapeutico transdermal con flujo aumentado de sustancia activa y tratamiento para su fabricacion.

Country Status (25)

Country Link
US (2) US5230898A (es)
EP (1) EP0391172B1 (es)
JP (1) JP2552191B2 (es)
KR (1) KR960007517B1 (es)
AT (1) ATE88911T1 (es)
AU (1) AU627283B2 (es)
CA (1) CA2013050C (es)
CZ (1) CZ284287B6 (es)
DD (1) DD293266A5 (es)
DE (2) DE3910543A1 (es)
DK (1) DK0391172T3 (es)
ES (1) ES2055201T3 (es)
FI (1) FI103478B1 (es)
HR (1) HRP930590B1 (es)
HU (1) HU205254B (es)
IE (1) IE65520B1 (es)
IL (1) IL93956A (es)
NO (1) NO180671C (es)
NZ (1) NZ233152A (es)
PL (1) PL163297B1 (es)
PT (1) PT93621B (es)
SI (1) SI9010635B (es)
SK (1) SK280782B6 (es)
YU (1) YU48321B (es)
ZA (1) ZA902465B (es)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE4110027C2 (de) * 1991-03-27 1996-08-29 Lohmann Therapie Syst Lts Verfahren zur Konfektionierung transdermaler therapeutischer Pflaster
DK170792B1 (da) * 1992-08-27 1996-01-22 Coloplast As Hudpladeprodukt til dosering af et eller flere medikamenter
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
AU667161B2 (en) * 1993-04-28 1996-03-07 Daiichi Pharmaceutical Co., Ltd. Butyrophenone transdermal compositions
EP0705097B2 (en) 1993-06-25 2004-01-14 Alza Corporation Incorporating poly-n-vinyl amide in a transdermal system
US5466465A (en) * 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
ATE200979T1 (de) * 1994-02-18 2001-05-15 Drossapharm Ag Transdermales therapeutisches system
JPH11506744A (ja) * 1995-06-07 1999-06-15 ノウブン ファーマシューティカルズ インク． 室温で液体である低分子量薬を含む経皮組成物
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
US5869089A (en) * 1996-03-21 1999-02-09 China-America Technology Corp. (Ctc) Manufacturing method of programmable transdermal therapeutic system
US7150881B2 (en) 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
DE19814087A1 (de) * 1998-03-30 1999-10-14 Lohmann Therapie Syst Lts Feuchtigkeitsaktivierbares therapeutisches System
WO2000033812A2 (en) * 1998-12-07 2000-06-15 Elan Corporation, Plc Transdermal patch for delivering volatile liquid drugs
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
US6183770B1 (en) 1999-04-15 2001-02-06 Acutek International Carrier patch for the delivery of agents to the skin
DE19918105C1 (de) * 1999-04-22 2000-09-21 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum
US6974588B1 (en) 1999-12-07 2005-12-13 Elan Pharma International Limited Transdermal patch for delivering volatile liquid drugs
WO2001066612A1 (de) * 2000-03-10 2001-09-13 Basf Aktiengesellschaft Verwendung von quervernetztem polyvinylpyrrolidon als sprengmittel in kompakten, teilchenförmigen wasch- und reinigungsmitteln
DE10012908B4 (de) * 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
DE10027258C1 (de) * 2000-05-31 2001-10-31 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit okklusiver wirkstoffhaltiger Schicht und nicht-okklusiver Rückschicht
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
DE10102817B4 (de) * 2001-01-23 2006-01-12 Lts Lohmann Therapie-Systeme Ag Vorrichtung und Verfahren zur Hitzepulsgestützten transdermalen Applikation von Wirkstoffen
US20050113510A1 (en) * 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8728445B2 (en) * 2001-05-01 2014-05-20 A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences Hydrogel Compositions
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
DE10136784A1 (de) * 2001-07-27 2003-02-20 Lohmann Therapie Syst Lts Darreichungsformen mit wirkstoffhaltigen Partikeln, zur Anwendung auf der Haut oder Schleimhaut
DE10159745A1 (de) 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
US20030147972A1 (en) * 2002-02-05 2003-08-07 Christopher W. Denver Method and composition for diminishing loss of color in flavors and fragrances
AR033748A1 (es) * 2002-05-15 2004-01-07 Thalas Group Inc Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
US20040086551A1 (en) * 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
US7383084B2 (en) 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
IL152574A (en) * 2002-10-31 2009-09-22 Transpharma Medical Ltd A system for passing through the skin of dry items or dried medicines
IL152575A (en) * 2002-10-31 2008-12-29 Transpharma Medical Ltd A skin-to-skin transmission system of water-insoluble drugs
US7662404B2 (en) * 2002-10-31 2010-02-16 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
IL152573A (en) * 2002-10-31 2009-11-18 Transpharma Medical Ltd A system for the transmission through the skin of a medical preparation against vomiting and nausea
US8133505B2 (en) 2002-10-31 2012-03-13 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
DE10251963A1 (de) * 2002-11-08 2004-05-19 Lts Lohmann Therapie-Systeme Ag Transmucosale pharmazeutische Darreichungsform
JP2005155749A (ja) 2003-11-25 2005-06-16 Nifco Inc パイプクランプ
US8658201B2 (en) * 2004-01-30 2014-02-25 Corium International, Inc. Rapidly dissolving film for delivery of an active agent
US9205062B2 (en) 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US20050202073A1 (en) 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
CN101039706A (zh) * 2004-08-05 2007-09-19 考里安国际公司 粘合剂组合物
ITMI20041697A1 (it) * 2004-09-03 2004-12-03 Bouty S P A Sistema terapeutico a rilascio controllato per uso topico in forma di cerotto multistrato
DE102004059674B4 (de) * 2004-12-10 2010-05-06 Acino Ag Transdermales System zur Abgabe von Scopolamin
EP1888001B1 (en) * 2005-06-10 2014-08-06 Syneron Medical Ltd. Patch for transdermal drug delivery
TWI419717B (zh) * 2005-06-17 2013-12-21 Altea Therapeutics Corp 滲透傳送系統及其使用方法
US7888422B2 (en) 2005-11-09 2011-02-15 Mylan Technologies Inc. Long-wearing removable pressure sensitive adhesive
US7955677B2 (en) * 2005-12-07 2011-06-07 Mylan Technologies, Inc. Two-sided non-stick release film
NL1031708C2 (nl) * 2006-04-27 2007-11-05 Advanced Chem Tech Beschermende bekleding voor op metaalhydride gebaseerde inrichtingen.
DE102006026578B4 (de) 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
US20080057090A1 (en) * 2006-09-01 2008-03-06 Mcentire Edward Enns Wrinkle masking film composition for skin
US7879942B2 (en) 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same
US9017301B2 (en) * 2007-09-04 2015-04-28 Mylan Technologies, Inc. Transdermal drug delivery systems comprising a coated release liner
EP2205967B1 (en) * 2007-10-17 2013-05-01 Syneron Medical Ltd. Dissolution rate verification
CA2704164A1 (en) 2007-10-29 2009-05-07 Transpharma Medical Ltd. Vertical patch drying
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
NZ604092A (en) * 2008-03-31 2015-08-28 Nitto Denko Corp Permeant delivery system and methods for use thereof
CA2662499A1 (en) * 2008-04-16 2009-10-16 Nitto Denko Corporation Transdermal drug administration device
AU2010204986B2 (en) 2009-01-14 2016-06-02 Corium International, Inc. Transdermal administration of tamsulosin
DE102009056746A1 (de) * 2009-12-04 2011-06-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung von Peptiden
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
US11058793B2 (en) 2011-05-16 2021-07-13 Avery Dennison Corporation Adhesive containing microparticles
DE102011090178A1 (de) 2011-12-30 2013-07-04 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit geringer Neigung zur Spontankristallisation
PL2954019T3 (pl) 2013-02-07 2019-01-31 Avery Dennison Corporation Kleje przeciwbakteryjne o ulepszonych właściwościach
US11213432B2 (en) 2013-03-15 2022-01-04 Avery Dennison Corporation Transparent cover dressing application system and inclusion of label strip
EP3151813B1 (en) 2014-06-05 2020-12-09 Avery Dennison Corporation Articles with active agent concentrated at the substrate contacting surface and related methods
KR101892270B1 (ko) * 2017-04-07 2018-08-27 주식회사 삼양사 피부자극을 최소화 할 수 있는 경피 흡수용 패취 시스템
WO2020110100A1 (en) * 2018-11-29 2020-06-04 Cannabidose Medical Ltd Devices for topical delivery of active agents to a target site
CN111610871A (zh) * 2019-02-25 2020-09-01 英属维尔京群岛商天材创新材料科技股份有限公司 电极结构及其触控面板
WO2022178120A1 (en) * 2021-02-18 2022-08-25 Agonex Biopharmaceuticals, Inc. Systems, devices, and formulations for time-phased histamine delivery

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1361289A (en) * 1971-06-14 1974-07-24 Alza Corp Bandage for administering drugs
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US3993072A (en) * 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US3996939A (en) * 1975-07-22 1976-12-14 National Catheter Corporation Intubation stylets
ATE12731T1 (de) * 1979-01-11 1985-05-15 Key Pharma Polymere diffusionsmatrix und verfahren zu deren herstellung.
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
US4314557A (en) * 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
US4834978A (en) * 1984-10-01 1989-05-30 Biotek, Inc. Method of transdermal drug delivery
ATE95430T1 (de) * 1984-12-22 1993-10-15 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster.
EP0196769B1 (en) * 1985-02-25 1992-07-08 Rutgers, The State University of New Jersey A novel transdermal pharmaceutical absorption dosage unit
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
EP0241806A1 (en) * 1986-04-14 1987-10-21 Fujisawa Pharmaceutical Co., Ltd. Sustained-release transdermal delivery preparations
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
ATE71287T1 (de) * 1986-06-13 1992-01-15 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
DK154806C (da) * 1986-12-19 1989-06-26 Coloplast As Saarplejemiddel indeholdende et aktivt stof til fremme af saarbehandlingen og fremgangsmaade til fremstilling deraf
US4837027A (en) * 1987-11-09 1989-06-06 Alza Corporation Transdermal drug delivery device
US4781924A (en) * 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US4942037A (en) * 1988-06-02 1990-07-17 Merck & Co., Inc. Transdermal delivery systems
SE8904296D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Transdermal system

Also Published As

Publication number Publication date
NO901458L (no) 1990-10-02
DE3910543C2 (es) 1993-01-07
PT93621A (pt) 1991-01-08
PL163297B1 (pl) 1994-03-31
IE65520B1 (en) 1995-11-01
JPH0327311A (ja) 1991-02-05
DK0391172T3 (da) 1993-09-27
FI103478B (fi) 1999-07-15
KR960007517B1 (ko) 1996-06-05
IL93956A0 (en) 1990-12-23
ZA902465B (en) 1991-01-30
HU902018D0 (en) 1990-08-28
DE3910543A1 (de) 1990-10-11
ATE88911T1 (de) 1993-05-15
FI103478B1 (fi) 1999-07-15
AU5131490A (en) 1990-10-04
KR900015704A (ko) 1990-11-10
PT93621B (pt) 1996-06-28
IL93956A (en) 1995-12-31
NZ233152A (en) 1991-12-23
DE59001338D1 (de) 1993-06-09
SK280782B6 (sk) 2000-07-11
CA2013050C (en) 1998-04-28
CA2013050A1 (en) 1990-10-01
EP0391172A1 (de) 1990-10-10
YU48321B (sh) 1998-05-15
HU205254B (en) 1992-04-28
FI901556A0 (fi) 1990-03-28
IE901175L (en) 1990-10-01
DD293266A5 (de) 1991-08-29
NO180671B (no) 1997-02-17
HRP930590B1 (en) 1997-10-31
US5702721A (en) 1997-12-30
JP2552191B2 (ja) 1996-11-06
CZ284287B6 (cs) 1998-10-14
SI9010635A (sl) 1998-06-30
YU63590A (en) 1991-10-31
HRP930590A2 (en) 1995-04-30
NO180671C (no) 1997-05-28
AU627283B2 (en) 1992-08-20
EP0391172B1 (de) 1993-05-05
SI9010635B (sl) 1998-12-31
NO901458D0 (no) 1990-03-30
US5230898A (en) 1993-07-27
CS9001483A2 (en) 1991-10-15
HUT54062A (en) 1991-01-28

Similar Documents

Publication Publication Date Title
ES2055201T3 (es) Sistema terapeutico transdermal con flujo aumentado de sustancia activa y tratamiento para su fabricacion.
YU12591A (sh) Postupak za izradu transdermalnog terapijskog sistema sa aktivnom materijom tulobuterolom
ATE48762T1 (de) System zur verabreichung von substanzen durch die haut.
ES2030026T3 (es) Sistema terapeutico transdermal, su aplicacion y procedimiento para su fabricacion.
AU622775B2 (en) A plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release, process for the production of the plaster and the use thereof
ATE109357T1 (de) Transdermales estradiol als therapeutisches sytem.
FR2441390A2 (fr) Materiau pour pansement liquide transparent, son procede de preparation et ses applications
ES8704740A1 (es) Procedimiento para preparar un producto farmaceutico para la entrega controlada de sustancias activas a la piel,preferentemente en forma de un emplasto
UA39884C2 (uk) Таблетка на основі клодронової кислоти, спосіб її одержання та спосіб лікування остеопорозу
ATE89756T1 (de) Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen.
FR2638234B1 (fr) Support pour molecules biologiquement actives ou lui-meme biologiquement actif, son procede de preparation et son application en biologie

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 391172

Country of ref document: ES